β-blocker use and risk of fractures in men and women from the general population:: the MONICA/KORA Augsburg cohort study

被引:50
作者
Meisinger, C.
Heier, M.
Lang, O.
Doering, A.
机构
[1] Ctr Hosp Augsburg, D-86156 Augsburg, Germany
[2] GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, Neuherberg, Germany
关键词
aging; epidemiology; osteoporosis; population studies; treatments;
D O I
10.1007/s00198-007-0354-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Use of beta-blockers is associated with a reduced risk of fractures in middle-aged and older subjects from the general population. Introduction The present prospective population-based study investigated the association between use of beta-blockers and incidence of any fracture. Methods The study was based on 1,793 persons 55 to 74 years of age who participated in one of the three MONICA Augsburg surveys between 1984 and 1995. Subjects were without any fracture at baseline. Incident fractures were assessed using a health questionnaire. Hazard ratios ( HRs) were estimated from Cox proportional hazard models. Results During a mean follow-up of 10.7 years, there occurred 263 incident fractures. beta-blocker users were older, were significantly more likely to be obese, to drink no alcohol, to have hypertension or diabetes, to use thiazides and statins, and to be physically inactive. The use of beta-blockers was associated with a lower risk of any fracture (HR 0.57; 95% CI= 0.36-0.90) after adjustment for age, sex and survey. Further adjustment for body mass index and education years only slightly attenuated the relationship ( HR 0.60; 95% CI= 0.38-0.95) and additional adjustment for a variety of further risk factors did not attenuate the association (HR 0.60; 95% CI= 0.37 - 0.96). Conclusion Use of beta-blockers was associated with a reduced risk of fractures in middle-aged and older subjects from the general population.
引用
收藏
页码:1189 / 1195
页数:7
相关论文
共 25 条
[1]   Effects of β-adrenergic agonists on bone-resorting activity in human osteoclast-like cells [J].
Arai, M ;
Nagasawa, T ;
Koshihara, Y ;
Yamamoto, S ;
Togari, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1640 (2-3) :137-142
[2]  
Baumann A, 1997, Gesundheitswesen, V59 Suppl 1, P19
[3]  
BRAY GA, 1978, INT J OBESITY, V2, P99
[4]   Chemical sympathectomy impairs bone resorption in rats: A role for the sympathetic system on bone metabolism [J].
Cherruau, M ;
Facchinetti, P ;
Baroukh, B ;
Saffar, JL .
BONE, 1999, 25 (05) :545-551
[5]   EFFECTS OF NEONATAL SYMPATHECTOMY AND CAPSAICIN TREATMENT ON BONE REMODELING IN RATS [J].
HILL, EL ;
TURNER, R ;
ELDE, R .
NEUROSCIENCE, 1991, 44 (03) :747-755
[6]  
Honkanen K, 1999, AM J EPIDEMIOL, V150, P511
[7]   Calcitonin gene-related peptide, substance P, and tyrosine hydroxylase-immunoreactive innervation of rat bone marrows: An immunohistochemical and ultrastructural investigation on possible efferent and afferent mechanisms [J].
Imai, S ;
Tokunaga, Y ;
Maeda, T ;
Kikkawa, M ;
Hukuda, S .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1997, 15 (01) :133-140
[8]   Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany - Results from the MONICA Augsburg cohort study 1984-1992 [J].
Keil, U ;
Liese, AD ;
Hense, HW ;
Filipiak, B ;
Doring, A ;
Stieber, J ;
Lowel, H .
EUROPEAN HEART JOURNAL, 1998, 19 (08) :1197-1207
[9]   A population comparison of participants and nonparticipants in a health survey [J].
Klesges, RC ;
Williamson, JE ;
Somes, GW ;
Talcott, GW ;
Lando, HA ;
Haddock, CK .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (08) :1228-1231
[10]  
Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785